Synovial biomarkers in psoriatic arthritis.

Author: AccordiBenedetta, CalabreseFiorella, CozziLuisella, DayerJean-Michel, Di MaggioAntonio, FelicettiMara, FioccoUgo, GazzolaKatia, Lo NigroAlessandro, LunardiFrancesca, MolenaBeatrice, NardacchioneRoberto, OlivieroFrancesca, PunziLeonardo, Roux-LombardPascale, RubaltelliLeopoldo, ScaglioriElena, SfrisoPaolo, StramareRoberto

Paper Details 
Original Abstract of the Article :
To find candidate biomarkers of psoriatic arthritis (PsA). A panel of synovial fluid (SF) and synovial tissue (ST) biomarkers was analyzed in patients with resistant peripheral PsA, in relation to clinical and imaging outcomes of synovitis response following serial intraarticular (IA) etanercept inj...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.3899/jrheum.120246

データ提供:米国国立医学図書館(NLM)

Synovial Biomarkers: Unlocking the Secrets of Psoriatic Arthritis

This research aims to identify [synovial biomarkers] that can help diagnose and manage [psoriatic arthritis (PsA)]. The authors analyzed a panel of biomarkers in [synovial fluid (SF) and synovial tissue (ST)] from patients with [resistant peripheral PsA] to determine their association with [clinical and imaging outcomes] following treatment with [intraarticular etanercept injections]. This research delves into the complex world of [biomarkers] and their potential for improving the diagnosis and management of autoimmune diseases.

Unlocking the Mysteries of Psoriatic Arthritis

This research is a crucial step towards [better understanding and treating] psoriatic arthritis. By identifying [synovial biomarkers] that are associated with [clinical and imaging outcomes], researchers can gain valuable insights into the [underlying mechanisms] of this complex disease. These biomarkers could be used to [personalize treatment] and improve outcomes for patients with PsA.

Harnessing the Power of Biomarkers

The search for [biomarkers] is a promising avenue for [advancing the field of medicine]. By identifying markers that can [predict disease progression, monitor treatment response, and guide personalized therapies], researchers are working towards a future where [medical interventions] are more precise and effective. This research demonstrates the potential of [biomarkers] to revolutionize the way we [diagnose and manage] a range of diseases, including PsA.

Dr.Camel's Conclusion

This research underscores the importance of [understanding the complex mechanisms] that drive autoimmune diseases like PsA. The quest for [biomarkers] is a vital step towards [developing better treatments] for these debilitating conditions. As we learn more about the [molecular signatures] of these diseases, we can hope to develop [personalized therapies] that are more targeted and effective.

Date :
  1. Date Completed 2012-10-17
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

22751595

DOI: Digital Object Identifier

10.3899/jrheum.120246

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.